Navigation Links
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
Date:12/23/2011

quired to conduct additional prospective studies or retrospective observational studies or to provide further analysis of clinical trial data; our response to questions and requests for additional information including additional pre-clinical or clinical studies from the European Medicines Agency, or EMA, and the Committee for Medicinal Products for Human Use, or CHMP, of the Marketing Authorization Application, or MAA, for Qnexa; the results of external studies to assess the teratogenic risk of topiramate; results of the REMS or cardiovascular outcomes for obesity advisory meetings; the outcome of the second advisory committee meeting for Qnexa; the impact, if any, of the agreement by one of our competitors with an obesity compound to conduct or complete a cardiovascular outcomes study pre-approval; impact on future sales based on specific indication and contraindications contained in the label and extent of the REMS, distribution and patient access program; the FDA's response to the NDA filed for avanafil; our ability to successfully commercialize or establish a marketing partnership for avanafil or our partner's ability to obtain regulatory approval to manufacture and adequately supply avanafil for commercial use; our history of losses and variable quarterly results; substantial competition; risks related to the failure to protect our intellectual property and litigation in which we may become involved; uncertainties of government or third party payer reimbursement; our reliance on sole source suppliers; our limited sales and marketing efforts and our reliance on third parties; failure to continue to develop innovative investigational drug candidates and drugs; risks related to the failure to obtain FDA or foreign authority clearances or approvals and noncompliance with FDA regulations; our ability to demonstrate through clinical testing the safety and effectiveness of our investigational drug candidates; our dependence on the performance of our collaborative par
'/>"/>
SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
4. VIVUS Announces Promotion of Peter Tam to President
5. VIVUS to Present at Lazard Capital Markets Healthcare Conference
6. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
7. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
8. VIVUS Announces Sale of MUSE Assets to Meda
9. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 Today, Rhodes ... nervous system stimulant indicated for the treatment of ... beginning Summer 2015. The announcement ... approval from the U.S. Food and Drug Administration ... extended-release formulation of methylphenidate capsule with an onset ...
(Date:5/22/2015)... REDWOOD CITY, Calif. , May 22, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that interim chief executive officer ... 2015 Healthcare Conference and chief financial officer Tim ... Science Conference. Details of the two presentations are as ...
(Date:5/21/2015)... 2015  When Ryan Rendino first felt ... his neck, he figured it was a ... off from weight lifting. But ... A series of doctor appointments ... Michel Kliot, MD , a ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... 24, 2012   Sanovas , a leading developer ... cancer and chronic diseases, announced today that it ... manufacturing site in Sausalito, Calif. The facility will ... of filing for U.S. Food and Drug Administration ...
... Medical Inc. (OTCBB:ONCS), which is developing its ... therapies to treat solid tumor cancers, today announced ... OncoSec, will be presenting at the World Cancer ... (Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
Cached Medicine Technology:Sanovas Expands Headquarters and Opens Manufacturing Site 2OncoSec to Present at World Cancer Immunotherapy Conference 2OncoSec to Present at World Cancer Immunotherapy Conference 3
(Date:5/24/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, ... sees many patients for concerns about hair loss. ... loss, it is clear that there are environmental factors ... of hormone that can contribute. Since they offer a ... aspects of the peri and post-menopausal woman, they can ...
(Date:5/24/2015)... May 24, 2015 Scientists with Cardno ... on air quality compliance issues that may have raised ... Surviving Mesothelioma has just posted an article on the ... , The group found airborne asbestos levels well above ... between 1984 and 2011. , “Asbestos compliance sampling data ...
(Date:5/24/2015)... ProPin is a set of self-animating ... Utilize ProPin to pin point locations on a map, to ... , ProPin allows users to choose from 30 simplistic presets with ... on-screen controls, video editors can easily manipulate ProPin presets as a ... with absolute ease. , Using ProPin is easy, simply drag a ...
(Date:5/24/2015)... Lake Geneva, WI (PRWEB) May 24, ... Bea Mercy Health System CEO ... their principal and honored at the ... event held April 15 at Geneva ... include (by school): ,     -Badger High ...
(Date:5/23/2015)... 23, 2015 On May 13, Nithyananda ... a youngster's yogic power learned through meditation and initiation ... in Bangalore, India. , Yogamaatha, a nine-year-old girl from ... high profile professionals attending the 2015 Business Advocacy Summit ... -- blindfolded. , In a demonstration that lasted ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3
... have discovered that targeting an enzyme called Uroporphyrinogen ... and chemotherapy, which could mean fewer side effects ... The findings, published online today in Science ... because they suggest that targeting UROD identified ...
... , WEDNESDAY, Jan. 26 (HealthDay News) -- ... has remained relatively stable over 15 million years, say ... five Bornean orangutans. Among the great apes, orangutans ... team of scientists found that the human and orangutan ...
... and Interventional Radiology the monthly, peer-reviewed flagship publication ... changes for 2011all directed at highlighting the global ... its lead journal. JVIR, which has been published ... minimally invasive, radiological, pathological and socioeconomic issues of ...
... Institute of Chicago (RIC), designated the "#1 Rehabilitation Hospital ... 1991, report that, thanks to improvements in technology and ... guide the development and operation of the brain could ... could herald a neuroscientific revolution, much as increasing processor ...
... from the University of North Carolina at Chapel Hill School ... that ensures the rapid conductance of nervous system impulses. The ... Neuron . Our hard-wired nerve fibers or axons rely ... fatty white matter to accelerate the rate of transmission of ...
... of its kind surgical quality improvement program for children has ... can be targeted for quality improvement efforts to prevent complications ... American College of Surgeons National Surgical Quality Improvement Program-Pediatric (ACS ... issue of the Journal of the American College of ...
Cached Medicine News:Health News:Princess Margaret Hospital researchers identify a key enzyme that affects radiation response 2Health News:Orangutan Genomes Reveal Some Surprises 2Health News:Journal of Vascular and Interventional Radiology debuts new look, reflects global impact 2Health News:Journal of Vascular and Interventional Radiology debuts new look, reflects global impact 3Health News:RIC study suggests researchers are entering a new era of advances in brain research 2Health News:Membrane molecule keeps nerve impulses hopping 2Health News:Membrane molecule keeps nerve impulses hopping 3Health News:First pediatric surgical quality program shows potential to measure children's outcomes 2
... the way for faster, easier, and more ... utilizes the latest digital FireWire technology, allowing ... images. Its ease of use allows technicians ... extraordinary time reduction frees technicians to perform ...
... The ADVIA 1200 system features a small footprint, which ... , , Standardization as Part of the ADVIA ... same reagents, calibrators and controls as the other members ... the same proven reliability. , , Meets Workload ...
... The Stryker Wedge Suture Anchors are ... sizes and styles. The Wedge anchors are ... surgeon and OR staff. The following sizes ... 1 Suture, 5.0mm Single Eyelet 2 Sutures, ...
RCB™ Rotator Cuff Buttress is a completely resorbable plate that will alleviate suture migration in open or mini-Open rotator cuff repairs....
Medicine Products: